Filters

Cefpodoxime proxetil manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

cefpodoxime proxetil

Syrup 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20110
This pharmaceutical contract manufacturer specializes in a wide range of dosage forms including tablets, capsules, injections, syrups, suspensions, and eye/ear drops. They operate across numerous key regions globally, with a strong presence in Africa, Asia Pacific, North America, and the EU. Their expertise spans several therapy areas such as generics, rare diseases, nutraceuticals, and functional ingredients. The company boasts several patented products and holds GMP certifications, ensuring high-quality manufacturing standards. They are known for their commitment to research and development, constantly innovating with new ingredients like Fibronectin for wound healing.

Manufacturer usually replies in 8 days

cefpodoxime proxetil

Tablets for oral solution 100 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19748
The company is a PCD pharma franchise provider in India, aiming to become a leader in delivering high-quality medications that address unmet medical needs globally. They differentiate themselves with a strong brand reputation, low investment requirements, a diverse product portfolio, and comprehensive support for franchisees, including setup guidance and training. Their offerings include a wide range of allopathic and ayurvedic medications produced using advanced German technology and adhering to WHO-GMP and ISO 9001-2015 standards. With an extensive network of distributors and retailers, the company offers a secure, low-risk business model for entrepreneurs looking to enter the pharmaceutical industry.

cefpodoxime proxetil

Tablets, soluble 50mg, 100mg, 200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19412
This pharmaceutical group is experiencing rapid growth, increasing its turnover from Rs. 1.5 crores in 2006 to Rs. 12 crores by 2009-2010 and aiming for Rs. 50 crores by 2015. While specific product details are not provided, the company operates across diverse therapeutic areas with a focus on both prescription medications and over-the-counter drugs. They highlight their management team's vision and dynamism, suggesting strong leadership driving their expansion within India.

Manufacturer usually replies in 27 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Cefpodoxime Proxetil

Cefpodoxime proxetil is an antibiotic that is effectively used to treat various bacterial infections such as Pneumonia, Sinusitis, tonsillitis, middle ear infections (otitis media), throat (pharyngitis) infections, urinary tract infections (UTIs), bronchitis, gonorrhea, as well as acute and chronic bronchitis bacterial in patients with chronic obstructive pulmonary disease. Skin structure or skin infections caused by susceptible bacteria and many other infections. This antibiotic works by destroying the cell walls of bacteria. Cefpodoxime proxetil is sold under the brand names Vantin and Banan amongst others. Pharmacia and Upjohn filed for the first patents and got the FDA approval for cefpodoxime proxetil in 1992.

Forms and Dosage

Cefpodoxime proxetil is available as tablets in 100 mg and 200 mg and granules for oral suspension in 50 and 100 mg/5 ml. In the treatment of pneumonia, bronchitis, or sinusitis, the adult dose is 200 mg every 12 hours for 10 to 14 days. While treating Gonorrhea, the recommended dose is 200 mg and for treating Urinary tract infections, the usual adult dose is 100 mg, taken every 12 hours for 7 to 14 days and for treating skin or skin structure infections, the usual adult dose is 00 mg, taken every 12 hours for 1 – 2 weeks.
The recommended dose for infants and children of 12 years is 5mg per kilogram of body weight, given orally, every 12 hours for 10 days with maximum dose capped at 200 mg and for treating Children for above 12 years, the usual pediatric dose is 200 mg, taken orally, every 12 hours for 10 days.

The Cost of Cefpodoxime Proxetil

In the USA, the consumer has to pay around $111.47 for a supply of 14 tablets of 200mg strength. Whereas in India, the prices are significantly cheaper at $44, for the supply of 100 tablets of 125mg.

How does Cefpodoxime Proxetil works?

Cefpodoxime Proxetil stops the bacteria growth in the body. As a Cephalosporin, it stops bacteria from multiplying by preventing bacteria from forming the cell walls around them. Bacteria need these walls to protect from their environment and to keep the contents of the bacterial cell together, without the wall the cell won't survive. Cefpodoxime proxetil gets converted to cefpodoxime, its active form once it enters the body.

Finding Cefpodoxime Proxetil Manufacturers and Suppliers

The best way to find and gain access to Cefpodoxime Proxetil manufacturers and Cefpodoxime Proxetil suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Cefpodoxime Proxetil can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Cefpodoxime Proxetil to work with. You can fine-tune your search results using various filters too, letting you search for Cefpodoxime Proxetil from specific countries.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.